Tranexamic Acid Reduces Blood Transfusion in Cardiac Surgery
Author Information
Author(s): Vuylsteke Alain, Saravanan Palanikumar, Gerrard Caroline, Cafferty Fay
Primary Institution: Papworth Hospital NHS Foundation Trust
Hypothesis
Does the administration of tranexamic acid reduce the use of blood products in cardiac surgery?
Conclusion
The administration of tranexamic acid decreased the number of patients needing blood transfusions and returning to theatre for bleeding.
Supporting Evidence
- Tranexamic acid significantly reduced the need for red blood cell transfusions.
- Patients receiving tranexamic acid had lower rates of returning to theatre for bleeding.
- Overall blood loss was significantly lower in patients treated with tranexamic acid.
Takeaway
Giving tranexamic acid helps patients have less bleeding and need fewer blood transfusions during heart surgery.
Methodology
Retrospective analysis of prospectively collected data from patients undergoing primary cardiac surgery.
Potential Biases
Potential bias in treatment allocation due to non-randomized design.
Limitations
The study did not investigate mortality or morbidity related to tranexamic acid use.
Participant Demographics
75% of patients were men, with a mean age of 67 years.
Statistical Information
P-Value
<0.001
Confidence Interval
0.44 (0.32 – 0.60)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website